nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-sectional study exploring triage of human papillomavirus (HPV)-positive women by visual assessment, manual and computer-interpreted cytology, and HPV-16/18–45 genotyping in Cameroon
|
Vassilakos, Pierre |
|
|
31 |
6 |
p. 808-816 |
artikel |
2 |
Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
|
Jeans, Elizabeth B |
|
|
31 |
6 |
p. 859-867 |
artikel |
3 |
Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
|
Merlotti, Anna |
|
|
31 |
6 |
p. 946 |
artikel |
4 |
Assessment of anastomotic perfusion using indocyanine green fluorescence angiography following bowel resection for gynecologic malignancies: an instructional surgical video
|
Spenard, Elisabeth |
|
|
31 |
6 |
p. 932-933 |
artikel |
5 |
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study
|
Daniele, Gennaro |
|
|
31 |
6 |
p. 875-882 |
artikel |
6 |
Chemotherapy response score as a prognostic tool in patients with advanced stage endometrial carcinoma treated with neoadjuvant chemotherapy
|
Jani, Ina |
|
|
31 |
6 |
p. 852-858 |
artikel |
7 |
Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer
|
Maene, Charlotte |
|
|
31 |
6 |
p. 824-828 |
artikel |
8 |
Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study
|
Donkers, Hannah |
|
|
31 |
6 |
p. 868-874 |
artikel |
9 |
Evaluating meaningful levels of financial toxicity in gynecologic cancers
|
Esselen, Katharine McKinley |
|
|
31 |
6 |
p. 801-806 |
artikel |
10 |
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic
|
Ayhan, Ali |
|
|
31 |
6 |
p. 883-887 |
artikel |
11 |
Financial toxicity is common among gynecologic cancer patients
|
Harrison, Ross F |
|
|
31 |
6 |
p. 807 |
artikel |
12 |
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
|
Mancebo, Gemma |
|
|
31 |
6 |
p. 914-919 |
artikel |
13 |
Immature teratoma with associated gliomatosis peritonei: image and brief review of literature
|
Schwartz, Cooper |
|
|
31 |
6 |
p. 940-941 |
artikel |
14 |
Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer
|
Ince, Christina |
|
|
31 |
6 |
p. 943 |
artikel |
15 |
Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study
|
Kumar, Divyesh |
|
|
31 |
6 |
p. 835-839 |
artikel |
16 |
Incorporating molecular profiling into endometrial cancer management requires prospective studies
|
Amant, Frédéric |
|
|
31 |
6 |
p. 944-945 |
artikel |
17 |
Lynch syndrome associated endometrial carcinomas in Western Australia: an analysis of universal screening by mismatch repair protein immunohistochemistry
|
Gupta, Surabhi |
|
|
31 |
6 |
p. 846-851 |
artikel |
18 |
Management of ovarian masses in pregnancy: patient selection for interventional treatment
|
Testa, Antonia Carla |
|
|
31 |
6 |
p. 899-906 |
artikel |
19 |
Management of Wolffian adnexal tumors
|
Kim, Soyoun Rachel |
|
|
31 |
6 |
p. 925-928 |
artikel |
20 |
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification
|
Jamieson, Amy |
|
|
31 |
6 |
p. 907-913 |
artikel |
21 |
Pelvic anatomy for gynecologic oncologists: autonomic bladder plexus
|
Díaz-Feijoo, Berta |
|
|
31 |
6 |
p. 936-937 |
artikel |
22 |
Practice patterns in post-treatment surveillance in patients with primary epithelial ovarian cancer
|
DeMari, Joseph |
|
|
31 |
6 |
p. 888-892 |
artikel |
23 |
Project ECHO in Belarus: outcomes of 3-year experience
|
Matylevich, Olga P |
|
|
31 |
6 |
p. 929-931 |
artikel |
24 |
Purple bag syndrome: a visual clue for infection
|
Wang, Victoria |
|
|
31 |
6 |
p. 942 |
artikel |
25 |
Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?
|
Concin, Nicole |
|
|
31 |
6 |
p. 947 |
artikel |
26 |
Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors
|
Nasioudis, Dimitrios |
|
|
31 |
6 |
p. 829-834 |
artikel |
27 |
Role of inhibin B in detecting recurrence of granulosa cell tumors of the ovary in postmenopausal patients
|
Portuesi, Rosalba |
|
|
31 |
6 |
p. 893-898 |
artikel |
28 |
Technique for inguino-femoral lymph node dissection in vulvar cancer: an international survey
|
Jones, Sadie Esme Fleur |
|
|
31 |
6 |
p. 817-823 |
artikel |
29 |
The impact of sentinel lymph node sampling versus traditional lymphadenectomy on the survival of patients with stage IIIC endometrial cancer
|
Nasioudis, Dimitrios |
|
|
31 |
6 |
p. 840-845 |
artikel |
30 |
Three-dimensional virtual histology of benign and malignant endometrial stromal neoplasms: a new perspective on why morphology matters
|
Kommoss, Felix KF |
|
|
31 |
6 |
p. 934-935 |
artikel |
31 |
TRAINING-Ovary 01 (connecTed pRehabiliAtIoN pelvIc caNcer surGery): multicenter randomized study comparing neoadjuvant chemotherapy for patients managed for ovarian cancer with or without a connected pre-habilitation program
|
Lambaudie, Eric |
|
|
31 |
6 |
p. 920-924 |
artikel |
32 |
Ultrasound, macroscopic and histological features of endometrioid and clear cell ovarian cancer
|
Bolomini, Giulia |
|
|
31 |
6 |
p. 938-939 |
artikel |